- How Daily Prunes Can Influence Cholesterol and Inflammation
- When to Take B12 for Better Absorption and Energy
- Epsom Salts: Health Benefits and Uses
- See What Saffron Can Do for Sleep and Heart Health
- 6 Common Mistakes to Avoid Before Your Physical
- Can Sweating Really Help You Beat a Cold?
- Strengthening Your Relationship: Practical Strategies
- Skip Storing This Everyday Product in the Fridge Door
- Green Tea + B3 Pairing May Boost Brain Health
- Navigating Your Midlife Crisis: Embracing New Possibilities
Bacteria May Help Battle Cancer, Study Suggests

Bacteria may offer a new way to treat cancer, a small, preliminary study suggests.
Researchers injected a weakened strain of Clostridium novyi-NT bacteria spores into tumors in six patients. The bacteria grew in the tumors and killed cancer cells, the investigators reported.
C. novyi-NT, which lives in soil, is a close relative of the bacteria that causes botulism. Before injecting C. novyi-NT into the patients, the researchers weakened it by removing its dangerous toxin.
Five of the six patients are still alive, while one died from unrelated causes several months after receiving the bacteria injection, according to the study to be presented Saturday at the annual Symposium on Clinical Interventional Oncology in Hollywood, Fla.
Research presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.
“When tumors reach a certain size, parts of them do not receive oxygen, which makes them resistant to conventional therapies such as radiation and chemotherapy,” study author Dr. Ravi Murthy, a professor of interventional radiology at M.D. Anderson Cancer Center in Houston, said in a symposium news release.
“C. novyi-NT thrives under these conditions, hones in on the low-oxygen areas and destroys tumors from the inside while sparing normal tissue,” Murthy explained.
C. novyi-NT also triggers an immune response to cancer.
“Essentially, C. novyi-NT causes a potent cancer-killing infection in the tumor,” study principal investigator Dr. Filip Janku, an associate professor in the department of investigation therapeutics at M.D. Anderson Cancer Center, said in the news release.
The new findings are very preliminary and much additional research into the potential therapy is needed.
More information
The U.S. National Cancer Institute has more about cancer treatments.
Source: HealthDay
Copyright © 2026 HealthDay. All rights reserved.










